Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Kds2010
2. 1894207-45-4
3. Schembl22769639
4. Glxc-20897
5. Ex-a8416
6. (s)-2-(((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)amino)propanamide Mesylate
| Molecular Weight | 418.4 g/mol |
|---|---|
| Molecular Formula | C18H21F3N2O4S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 118 |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 476 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
ABOUT THIS PAGE
22
PharmaCompass offers a list of KDS2010 mesylate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right KDS2010 mesylate manufacturer or KDS2010 mesylate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred KDS2010 mesylate manufacturer or KDS2010 mesylate supplier.
PharmaCompass also assists you with knowing the KDS2010 mesylate API Price utilized in the formulation of products. KDS2010 mesylate API Price is not always fixed or binding as the KDS2010 mesylate Price is obtained through a variety of data sources. The KDS2010 mesylate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A KDS2010 mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of KDS2010 mesylate, including repackagers and relabelers. The FDA regulates KDS2010 mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. KDS2010 mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A KDS2010 mesylate supplier is an individual or a company that provides KDS2010 mesylate active pharmaceutical ingredient (API) or KDS2010 mesylate finished formulations upon request. The KDS2010 mesylate suppliers may include KDS2010 mesylate API manufacturers, exporters, distributors and traders.
KDS2010 mesylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of KDS2010 mesylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right KDS2010 mesylate GMP manufacturer or KDS2010 mesylate GMP API supplier for your needs.
A KDS2010 mesylate CoA (Certificate of Analysis) is a formal document that attests to KDS2010 mesylate's compliance with KDS2010 mesylate specifications and serves as a tool for batch-level quality control.
KDS2010 mesylate CoA mostly includes findings from lab analyses of a specific batch. For each KDS2010 mesylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
KDS2010 mesylate may be tested according to a variety of international standards, such as European Pharmacopoeia (KDS2010 mesylate EP), KDS2010 mesylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (KDS2010 mesylate USP).
